have you looked at OPXA? anther to consider, have deal with Merck
really low price, what else in pipeline
thanks
another example is ELN they never got back to there ultimate high of $61, but did recover some.
Sentiment: Hold
Possible buyout and they can advance on technology, given small MC, but for what price?
Sentiment: Strong Buy
DNDN was $58 and has been stuck under $10 and at one time $3.69?
doesn't mean anything in the world of biotechs. This could stay at $3-3.50 range for quite some time. Don't think it'll spring back to $25 soon.
CLSN dropped from $9 to $1, might get a small pop soon but unless news comes out it'll stay under $2 and that goes for many bio-tech stocks out there.
Sentiment: Hold
call next week, expect a nice pop
Don't forget CLSN, still in the game.
Sentiment: Strong Buy
CLSN will pop before earnings next thursday. should hit $1.50
Sentiment: Strong Buy
thanks, sounds like a better plan.
Sentiment: Buy
10 bagger if you are smart load up!
Sentiment: Strong Buy
I guess smart minds think alike , hmm
I am but would like Longs input, always helps. Too much trash out there if you know what I mean ;)
get lost punk!
Sentiment: Buy
this part is important:
Subset data analysis could come at any time, and this will likely be the catalyst for a bounceback.
Sentiment: Buy
This was a stock we profiled last month in our article, "Speculative Boiptech Stocks That Could Bounce", and in that article, we noted the oversold chart and the expected move back to $1.60. A week later, the stock popped to an intra-day high of $1.54 for a 30% gain. Since then, there has been a slow bleed, thanks to news of financing competed at $1.24 per share. Now that financing has been completed, the company has approximately $35m in cash. Celsion has been consolidating over the last two weeks since that news at the $1 level, and could be setting up for another bounceback. Subset data analysis could come at any time, and this will likely be the catalyst for a bounceback. Also, with the financing completed at $1.24 and the stock hovering at $1, there is good reason to expect a bounce back to that price level near term. With a market cap of $50m and some small hope for positive news in their other trials there is reason to put some speculative money in this play. A bounce back to the February $1.54 highs would mark a 50% return from here.
Sentiment: Buy
You are a smart investor, buyout not happening with what is going on. This will drift sideways for some time and possibly have some pops here and there. Who ever bought/shorted/covered did there thing for what ever reasons. Retailers are always the last to know.
Anything can happen but looking at it realistically I would be cautious.
Sentiment: Hold
Earnings Call should give some clarity to future of CLSN, expect a small pop going into earnings.
Sentiment: Buy
what "if"
I don't know, this is really risky investment.
Sentiment: Hold
You are stating that AFFY met with Pfizer? Can you support this claim?
Sentiment: Hold
hold your shares.
Sentiment: Buy